Skip to content

Responding to the challenge of MERS-CoV: development and testing of interventions to reduce risk among Bedouin populations in Southern Jordan

Effects of a behavioural intervention to reduce MERS-CoV exposure among camel-owning households in southern Jordan: a randomised controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN57906829
Enrollment
1200
Registered
2024-11-28
Start date
2022-09-30
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Middle East Respiratory Syndrome among camel-owning households in Jordan Infections and Infestations

Interventions

Block randomisation, block size 6, with even numbers assigned to the intervention group, odd numbers to the control group Primary interventions: Package 1. Zoonotic camel-to-human MERS-CoV transmiss

Sponsors

Royal Veterinary College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Member of a randomly selected camel-owning household (from Ministry of Agriculture lists) in southern Jordan (Ma'an and Aqaba governorates)

Exclusion criteria

Exclusion criteria: 1. Children younger than 5 years 2. Individuals without the capacity to provide informed consent

Design outcomes

Primary

MeasureTime frame
Self-reported and observed behaviours from intervention package 1 (i.e., face-covering when working with camels, avoiding kissing camels, filling troughs before allowing camels access and washing hands after working with camels), quantified as binary outcomes, measured 6 months after delivery if the intervention package

Secondary

MeasureTime frame
1. Self-reported behaviours quantified as binary outcomes from intervention packages 2 – 4, measured 6 months after delivery if the intervention package 2. Qualitative data regarding intervention uptake, resulting from thematic and discourse analysis of semi-structured interviews, measured 6 months after delivery if the intervention package 3. Serological status on in-house MERS-CoV Spike protein (S1) IgG ELISA, measured 6 months after delivery if the intervention package

Countries

Jordan

Contacts

Public ContactJavier;Punam Guitian;Mangtani

;

JGuitian@RVC.AC.UK;Punam.Mangtani@lshtm.ac.uk+44 (0)20 7468 5000;+44 (0)20 7636 8636

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026